For example, SOCS2 could inhibit the activity of Janus kinase 2 (JAK2) and reduce JAK2–STAT3 binding in head and neck squamous cell carcinoma (HNSCC)10. This evidence concerns the gene JAK2 and head and neck squamous cell carcinoma.